Hyaluronic%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252520acid

# Hyaluronic acid ## Overview Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found in connective tissues, synovial fluid, and ocular tissues. It acts as a lubricant and shock absorber. Injectable formulations are derived from microbial fermentation. ## Primary Indications * **Intra-articular injection:** Osteoarthritis of the knee. * **Ophthalmic surgery:** Viscosurgical device for anterior chamber maintenance and corneal protection during cataract surgery and other intraocular procedures. * **Dermal filler:** Aesthetic correction of facial wrinkles and folds. * **Topical formulations:** Skin hydration and wound healing (efficacy less established than injectable forms). ## Adult Dosing Dosing varies significantly by indication and product. * **Osteoarthritis of the knee:** * **Synvisc-One:** 6 mL intra-articular injection once. * **Synvisc:** 2 mL intra-articular injection once weekly for 3 weeks. * **Euflexxa:** 2 mL intra-articular injection once weekly for 3 weeks. * **Durolane:** 3 mL intra-articular injection once. * **Other products:** Follow manufacturer specific instructions, typically 2-3 mL intra-articular injections given weekly for 3-5 weeks. Maximum of 5 injections per course. * **Ophthalmic surgery:** Administered by an ophthalmologist during surgery. Volume varies based on procedure, typically 0.5 mL to 2 mL. * **Dermal filler:** Administered by a qualified healthcare professional. Volume depends on the area treated and desired outcome. ## Pediatric Dosing No established pediatric dosing for intra-articular or ophthalmic indications. Safety and efficacy have not been studied. ## Dose Adjustments * **Renal/Hepatic Impairment:** No dose adjustments typically required as HA is metabolized locally or systemically without relying on specific organ clearance pathways. ## Contraindications * Active infection in or around the joint to be injected. * Known hypersensitivity to hyaluronic acid or its components. * Skin infection at the injection site. ## Adverse Effects * **Intra-articular:** Pain, swelling, stiffness, warmth, redness at the injection site. Transient joint effusion. * **Ophthalmic:** Transient blurred vision, increased intraocular pressure, inflammation. * **Dermal filler:** Bruising, swelling, redness, pain, itching, nodules, infection, allergic reactions. ## Key Drug Interactions * **Intra-articular:** Concurrent use of corticosteroids or NSAIDs in the same joint may alter efficacy or safety profiles. Consult specific product information. * **Ophthalmic:** Avoid concurrent use with other ophthalmic medications that may affect intraocular pressure or inflammation. ## Monitoring * **Intra-articular:** Monitor for signs of infection or significant joint effusion. Assess pain relief and functional improvement. * **Ophthalmic:** Monitor intraocular pressure and for signs of inflammation post-operatively. * **Dermal filler:** Monitor for adverse reactions such as infection, inflammation, or nodule formation. ## Clinical Pearls * Hyaluronic acid for osteoarthritis is a viscosupplement, not a cure. Effects may take several weeks to become apparent and can last for months. * Multiple products exist with varying molecular weights and cross-linking, leading to different durations of action and administration schedules. * Proper injection technique is crucial to minimize adverse events. * For ophthalmic use, HA acts as a viscoelastic agent to protect delicate ocular tissues. *** *Disclaimer: This information is intended for healthcare professionals. Always consult the most current prescribing information and product literature for complete details, including indications, contraindications, warnings, precautions, and adverse reactions, before prescribing or administering any medication.*